VSTM: Verastem, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 255.39
Enterprise Value ($M) 238.46
Book Value ($M) -28.89
Book Value / Share -0.56
Price / Book -8.84
NCAV ($M) -35.47
NCAV / Share -0.69
Price / NCAV -7.20

Profitability (mra)
Return on Invested Capital (ROIC) -5.59
Return on Assets (ROA) -1.06
Return on Equity (ROE) -2.83

Liquidity (mrq)
Quick Ratio 3.07
Current Ratio 3.07

Balance Sheet (mrq) ($M)
Current Assets 94.96
Assets 101.54
Liabilities 130.43
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 10.00
Operating Income -114.96
Net Income -130.64
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -104.77
Cash from Investing 59.97
Cash from Financing 54.78

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-21 13G/A Barclays Plc 8.87 0.00
02-14 13G Balyasny Asset Management Llc 8.87
02-14 13G/A Alyeska Investment Group, L.P. 2.10 -65.03
02-14 13G/A Biotechnology Value Fund L P 9.99 9.98
02-14 13G/A Nantahala Capital Management, LLC 9.99
02-13 13G/A Stonepine Capital Management, LLC 4.80 -16.65
02-11 13G/A Soleus Capital Master Fund, L.P. 7.30 135.03
01-31 13G Vanguard Group Inc 5.19 -73.88
01-21 13G Hirschman Orin 6.10
11-14 13G/A Orbimed Advisors Llc 9.90 171.32
11-14 13G/A Soleus Private Equity Fund III, L.P. 8.70
11-14 13G/A Flynn James E 0.00 -100.00
11-14 13G/A Viking Global Investors Lp 0.00 -100.00
11-12 13G/A Adage Capital Management, L.P. 0.00
11-08 13G BlackRock, Inc. 5.60 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES
2024-08-08 10-Q UNITED STATES
2024-05-09 10-Q UNITED STATES

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 229,590 955,432 24.03
2025-04-16 103,539 430,422 24.06
2025-04-15 161,446 703,071 22.96
2025-04-14 46,778 406,445 11.51

(click for more detail)

Similar Companies
UPXI – Upexi, Inc. VERU – Veru Inc.
VKTX – Viking Therapeutics, Inc. VTGN – Vistagen Therapeutics, Inc.
VTVT – vTv Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Verastem